Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	0.10	-61.12	61.06
Graham Fair Price	-49.55	56.93	112.84
PEG	-78.39	0.63	-2.93
Price/Book	-5.18	5.20	5.49
Price/Cash Flow	1320.83	1124.62	-79.15
Prices/Earnings	258.55	-80.02	22.32
Price/Sales	-12.37	4.52	5.16
Price/FCF	1320.83	1124.62	-79.15
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.07	0.23	0.23
Operating Margin	-2.40	0.08	0.08
ROA	-74.70	< 0.005	0.02
ROE	0.06	-0.02	-73.55
ROIC	0.04	-60.40	144529.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	0.06	43.34
Dividends QOQ	< 0.005	< 0.005	44.36
EBIT QOQ	-0.10	0.03	-67.94
EPS QOQ	-0.08	-1.26	-1559.58
FCF QOQ	-2.01	1.07	-47.12
Revenue QOQ	0.02	0.06	154.19
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-85.24	-87.78	-2.97
Days Sales Outstanding (DSO)	37.14	41.92	12.86
Inventory Turnover	-1.06	-1.03	2.89
Debt/Capitalization	0.42	0.46	10.05
Quick Ratio	0.69	0.76	9.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	95.96	94.13	-1.90
Cash	32.03	35.52	10.88
Capex	-1.04	-0.81	22.19
Free Cash Flow	-6.65	0.44	-93.45
Revenue	102.09	108.37	6.15
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.79	0.85	7.55
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.85	-5.57	14.88
Naive Interpretation	Member

06 - Financial Health · Bad

Rating